Volume 10, Number 11—November 2004
Research
Evaluating Human Papillomavirus Vaccination Programs
Table 1
Age category (y) | New sex partners/y (%)
(12–14) |
Mixing between age categories (%)
(12–14)c |
Initial HPV prevalence (%) (15–18)d |
Duration HPV shedding (%)
(19–21)e |
||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Female |
Male |
Female |
Male |
HPV 16 |
HPV 18 |
|||||||||||||||
0 | 1 | 2–4 | 5+ | 0 | 1 | 2–4 | 5+ | < | = | > | < | = | > | Female | Male | Female | Male | Stop shedding | Completely regress | |
<18 | 64 | 30 | 5 | 1 | 57 | 30 | 11 | 1 | 64 | 36 | 90 | 10 | 2.6 | 3.5 | 0.9 | 1.2 | 55 | 49 | ||
18–20 | 55 | 26 | 15 | 4 | 50 | 25 | 19 | 6 | 1 | 61 | 38 | 18 | 72 | 11 | 4.3 | 5.0 | 1.8 | 2.1 | 55 | 49 |
21–23 | 55 | 26 | 15 | 4 | 50 | 25 | 19 | 6 | 3 | 59 | 38 | 32 | 58 | 10 | 4.6 | 5.0 | 2.2 | 2.3 | 55 | 49 |
24–26 | 76 | 19 | 4 | 1 | 66 | 21 | 12 | 2 | 11 | 51 | 38 | 34 | 56 | 10 | 3.0 | 3.4 | 1.5 | 1.7 | 37 | 33 |
27–29 | 83 | 12 | 4 | 1 | 71 | 15 | 12 | 2 | 11 | 51 | 38 | 34 | 56 | 10 | 1.7 | 2.7 | 0.8 | 1.4 | 37 | 33 |
30–34 | 89 | 7 | 4 | 1 | 76 | 10 | 12 | 2 | 10 | 49 | 41 | 38 | 49 | 13 | 1.0 | 2.1 | 0.5 | 1.1 | 37 | 7 |
35–39 | 90 | 6 | 3 | 0 | 81 | 9 | 9 | 1 | 13 | 50 | 37 | 36 | 49 | 15 | 0.7 | 1.5 | 0.4 | 0.8 | 37 | 7 |
40–44 | 90 | 6 | 3 | 0 | 81 | 9 | 9 | 1 | 15 | 48 | 37 | 39 | 47 | 15 | 0.5 | 1.1 | 0.3 | 0.6 | 37 | 7 |
>45 | 94 | 5 | 1 | 0 | 90 | 6 | 3 | 0 | 15 | 85 | 39 | 62 | 0.4 | 0.7 | 0.2 | 0.4 | 37 | 7 |
aHPV, human papillomavirus.
bMixing between sexual activity categories was assumed to be assortive (22). Relative preference for within-group mixing was estimated by [% of potential partners in group X] / [(% of potential partners in group X) + α(1 – % of potential partners in group X)], where α (the assortment variable) ranged from 0.4 for relatively assortive mixing (base-case value) to –0.4 for relatively disassortive mixing.
cFor each age group, percentage of partners for persons who are in younger (<), the same (=), or older (>) age groups.
dEstimate of the prevaccination natural history of HPV infection.
eProbability that within 1 year a person of a given age group will stop shedding HPV and the probability that HPV infection will completely regress.